Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats
- 1 March 2015
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 201, 32-40
Abstract
No abstract availableKeywords
Funding Information
- Raymond Kwok Family Research Fund, USA
- King Khaled Eye Specialist Hospital of Saudi Arabia
- Eye Bank Association of America/Richard Lindstrom Research Grant 2012
- NIH (P30EY001765)
This publication has 38 references indexed in Scilit:
- Nanotechnology approaches for ocular drug deliveryMiddle East African Journal of Ophthalmology, 2013
- A Dense Poly(Ethylene Glycol) Coating Improves Penetration of Large Polymeric Nanoparticles Within Brain TissueScience Translational Medicine, 2012
- Flt23k Nanoparticles Offer Additive Benefit in Graft Survival and Anti-Angiogenic Effects When Combined with TriamcinoloneInvestigative Ophthalmology & Visual Science, 2012
- Intravitreal poly(l-lactide) microparticles sustain retinal and choroidal delivery of TG-0054, a hydrophilic drug intended for neovascular diseasesDrug Delivery and Translational Research, 2010
- Ophthalmic Drug Delivery Systems for the Treatment of Retinal Diseases: Basic Research to Clinical ApplicationsInvestigative Ophthalmology & Visual Science, 2010
- Recent Advances in Ophthalmic Drug DeliveryTherapeutic Delivery, 2010
- Mechanisms and resistance in glucocorticoid control of inflammationThe Journal of Steroid Biochemistry and Molecular Biology, 2010
- Efficient encapsulation of a water-soluble corticosteroid in biodegradable nanoparticlesInternational Journal of Pharmaceutics, 2009
- Role of zinc in formulation of PLGA/PLA nanoparticles encapsulating betamethasone phosphate and its release profileJournal of Controlled Release, 2005
- Immunosuppression in corneal transplantationEye, 1995